Topical administration of adrenergic receptor pharmaceutics and nerve growth factor
Jena J SteinleDepartments of Ophthalmology and Anatomy and Neurobiology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USAAbstract: Topical application of nerve growth factor (NGF) and adrenergic receptor pharmaceutics are currently in use for corneal ulce...
Guardado en:
Autor principal: | Jena J Steinle |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c4cdf5096d84ba2b8ac48694f98ec89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Resolution of persistent corneal erosion after administration of topical rebamipide
por: Kashima T, et al.
Publicado: (2012) -
Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration
por: Gail Torkildsen, et al.
Publicado: (2010) -
The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients
por: McVeigh KA, et al.
Publicado: (2015) -
Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
por: Carreras A, et al.
Publicado: (2012) -
Topical azithromycin or ofloxacin for endophthalmitis
por: Stewart ML, et al.
Publicado: (2012)